Catecholaminergic activity and 3',5'-cyclic adenosine monophosphate levels in heart right ventricle after naloxone induced withdrawal

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 361, Issue 1, 2000, Pages 61-66

  Milanes M V ^a   Fuente, T ^a   Laorden, M L ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

3',4' cyclic adenosine monophosphate; Dopamine; Noradrenaline; Opioid dependence; Right ventricle

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; BETA ADRENERGIC RECEPTOR; CYCLIC AMP; DOPAMINE; MORPHINE; NALOXONE; NORADRENALIN; NORMETADRENALIN; PROPRANOLOL;

ADAPTATION; ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE METABOLISM; CATECHOLAMINE NERVE CELL; CONTROLLED STUDY; DOPAMINE METABOLISM; HEART RIGHT VENTRICLE; MALE; MORPHINE ADDICTION; NERVE CELL EXCITABILITY; NONHUMAN; PATHOPHYSIOLOGY; RAT; WITHDRAWAL SYNDROME;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BEHAVIOR, ANIMAL; CATECHOLAMINES; CYCLIC AMP; DOPAMINE; HEART VENTRICLES; MALE; MORPHINE DEPENDENCE; MYOCARDIUM; NALOXONE; NARCOTIC ANTAGONISTS; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0033959778     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002109900165     Document Type: Article

References (35)

1. Aghajanian GK, Wang YY (1987) Common alpha-2 and opiate effector mechanisms in the locus coeruleus: intracellular studies in brain slices. Neuropharmacology 26:789-800
2. Chang APL, Dixon WR (1990) Role of plasma catecholamines in eliciting cardiovascular changes seen during naloxone-precipitated withdrawal in conscious, unrestrained morphine-dependent rats. J Pharmacol Exp Ther 254:857-863
3. Couceyro P, Douglass J (1995) Precipitated morphine withdrawal stimulates multiple activator protein-1 signaling pathways in rat brain. Mol Pharmacol 47:29-30
4. Cruz SL, Villareal JE (1993) Acute opioid dependence in the cardiovascular system of the spinal rat. J Pharmacol Exp Ther 265:128-133
5. Dixon WR, Chandra A (1987) The effect of naloxone on blood catecholamine levels in conscious unrestrained morphine dependent rats. Proc West Pharmacol Soc 30:167-170
6. Eisenhofer G, Smolich JJ, Esler MD (1992) Increased cardiac production of dihydroxyphenylanine (DOPA) during sympathetic stimulation in anaesthetized dogs. Neurochem Int 21:37-44
7. Elayan H, Kennedy B, Zieglel MG (1992) Propranolol reduces rat dopamine B-hydroxylase activity and catecholamine levels. Eur J Pharmacol 212:259-262
8. Gonzálvez ML, Milanés MV, Martínez-Piñero MG, Marín MT, Vargas ML (1994) Effects of intracerebroventricular clonidine on the hypothalamic noradrenaline and plasma corticosterone levels of opiate naïve rats and after naloxone-induced withdrawal. Brain Res 647:199-203
9. Guitart X, Thompson MA, Mirante CK, Greenberg ME, Nestler EJ (1992) Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J Neurochem 58:1168-1171
10. Gutterman DD (1996) Central integration of autonomic control of the heart. Including the coronary circulation. In: Shepherd JT, Vatner SF (eds) Nervous control of the heart. Harwood. Amsterdam, pp 253-294
11. Holaday JW (1983) Cardiovascular effects of endogenous opiate system. Annu Rev Pharmacol Toxicol 23:541-594
12. Jin WQ, Tai KK, Chau TK, Wong TM (1995) Further characterization of [3H]U69593 binding sites in the rat heart. J Mol Cell Cardiol 27:1507-1511
13. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184
14. Maldonado R (1997) Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci Biobehav Rev 21:91-104
15. Manzanares J, Lookingland KK, Moore KE (1990) Kappa-opioid receptor-mediated regulation of a-melanocyte stimulating hormone secretion and tuberohypophyseal dopaminergic neuronal activity. Neuroendocrinology 52:200-205
16. Milanés MV, Rabadán JV, Laorden ML (1997) Effects of chronic U-50,488H treatment on the isolated right atrium of the rat. Neuropeptides 31:511-515
17. Milanés MV, Laorden ML (1998) Effects of U-50,488H withdrawal on catecholaminergic neurons of the rat ventricle. Br J Pharmacol 124:1060-1064
18. Milanés MV, Rabadán JV, Laorden ML (1998) Effects of U-50,488H on isolated from rats chronically treated with the k-opioid agonist, U-50,488H. J Auton Pharmacol 18:371-375
19. Nestler EJ (1992) Molecular mechanisms of drug reinforcement and addiction. J Neurosci 12:2493-2450
20. Nestler E, Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278:58-63
21. Nestler EJ, Hope BT, Widnell KL (1993) Drug addiction: a model for molecular basis of neural plasticity. Neuron 11:995-1006
22. Ohta A, Kaneto H (1992) Development of physical dependence on morphine not accompanied with tolerance formation. J Pharmacobiodyn 14:443-447
23. Olson GA, Olson RD, Kasting AJ (1994) Endogenous opiates: 1993. Peptides 15:1513-1556
24. Rabadán JV, Milanés MV, Laorden ML (1997) Effects of chronic morphine treatment on catecholamines content and mechanical response in the rat heart. J Pharmacol Exp Ther 280:32-37
25. Rabadán JV, Milanés MV, Laorden ML (1998) Changes in right atria catecholamines content in naïve rats and after naloxone-induced withdrawal. Br J Anaesth 80:354-359
26. Rezayat M, Azizi N, Zarrindast MR (1997) On the mechanisms of cholecystokinin (CCK): receptor stimulation attenuates morphine dependence in mice. J Pharmacol Toxicol 81:124-129
27. Self DW, Nestler EJ (1995) Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci 18:463-495
28. Selley DE, Nestler EJ, Breivogel CS, Childers SR (1997) Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatment. Brain Res 746:10-18
29. Steele PA, Aromatais EC, Riederer BM (1996) Endogenous opioid peptides parasympathetic and sensory nerves in the guinea-pig heart. Cell Tissue Res 284:331-339
30. Tokuyama S, Feng Y, Wakabayashi H, Ho IK (1995) Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8. Eur J Pharmacol 284:101-107
31. Valverde O, Tzavara E, Hanoune J, Roques BP, Maldonado R (1997) Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal. Eur J Neurosci 8:2671-2678
32. Vargas ML, Martínez-Piñero MG, Milanés MV (1997) Neurochemical activity of noradrenergic neurons and pituitary-adrenal response after naloxone-induced withdrawal: the role of calcium channels. Naunyn-Schmiedeberg's Arch Pharmacol 355:501-506
33. Wegener A, Kunmer W (1994) Sympathetic noradrenergic fibers as the source of immunoreactive alpha-neoendorphin and dynorphin in the guinea-pig heart. Acta Anat (Basel) 151:112-119
34. Weihe E, McKnight AT, Corbbet AD, Kosterlitz HW (1985) Proenkephalin-and prodynorphin-derived opioid peptides in guinea-pig heart. Neuropeptides 5:453-456
35. Witer G, Hope P, Pile D (1996) Tissue distribution of opioid receptor gene expression in the rat. Biochem Biophys Res Commun 218:877-881